Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Capital Expenditures (2018 - 2026)

Exagen filings provide 9 years of Capital Expenditures readings, the most recent being $228000.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 101.77% to $228000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $756000.0, a 39.48% increase, with the full-year FY2025 number at $641000.0, up 24.47% from a year prior.
  • Capital Expenditures hit $228000.0 in Q1 2026 for Exagen, down from $624000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.9 million in Q2 2022 to a low of -$656000.0 in Q4 2023.
  • Median Capital Expenditures over the past 5 years was $209000.0 (2025), compared with a mean of $339294.1.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 7250.0% in 2024 and later plummeted 307.48% in 2025.
  • Exagen's Capital Expenditures stood at $406000.0 in 2022, then plummeted by 261.58% to -$656000.0 in 2023, then skyrocketed by 122.26% to $146000.0 in 2024, then soared by 327.4% to $624000.0 in 2025, then plummeted by 63.46% to $228000.0 in 2026.
  • The last three reported values for Capital Expenditures were $228000.0 (Q1 2026), $624000.0 (Q4 2025), and -$305000.0 (Q3 2025) per Business Quant data.